Urology
Volume 70, Issue 6, Supplement 1 , Pages S9-S15 , December 2007

Focal Cryosurgery Followed by Penile Rehabilitation as Primary Treatment for Localized Prostate Cancer: Initial Results

  • David S. Ellis

      Affiliations

    • Urology Associates of North Texas, Arlington, Texas, USA
    • United States Medical Development, Irving, Texas, USA
    • Corresponding Author InformationReprint requests: David S. Ellis, MD, Urology Associates of North Texas, 1001 Waldrop Drive, Suite 708, Arlington, Texas 76012.
    • Dr. Ellis is a proctor for Endocare, Inc.
    • ,
  • Theodore B. Manny Jr.

      Affiliations

    • University of Texas Southwestern Medical School, Dallas, Texas, USA
    • Dr. Manny Jr. has no financial arrangement or affiliation with a corporate organization or a manufacturer of a product discussed in this supplement.
    • ,
  • John C. Rewcastle

      Affiliations

    • Department of Radiology, University of Calgary, Calgary, Alberta, Canada
    • Endocare, Inc., Irvine, California, USA
    • Dr Rewcastle has no financial arrangement or affiliation with a corporate organization or a manufacturer of a product discussed in this supplement.

References 

  1. American Cancer Society. Cancer Facts and Figures 2006. Atlanta, Georgia: American Cancer Society; 2006;
  2. Onik G, Narayan P, Vaughan D, et al. Focal “nerve-sparing” cryosurgery for treatment of primary prostate cancer: a new approach to preserving potency. Urology. 2002;60:109–114
  3. Bahn DK, Silverman P, Lee F, et al. Focal prostate cryoablation: initial results show cancer control and potency preservation. J Endourol. 2006;20:688–692
  4. Donnelly BJ, Saliken J. Salvage cryosurgery—how I do it. Rev Urol. 2002;4(suppl 2):S24–S28
  5. Ellis DS. Cryosurgery as primary treatment for localized prostate cancer: a community hospital experience. Urology. 2002;60(suppl 1):34–39
  6. American Society for Therapeutic Radiology and Oncology Consensus Panel. Consensus statement: guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys. 1997;37:1035–1041
  7. Masson P, Prepelica KL, Lambert EH, et al. Focal cryosurgery, encouraging outcomes for unifocal prostate cancer. 2004;Presented at the 2004 Annual Meeting of the American Urological Association; May 9 to 12, San Francisco, California
  8. Robinson JW, Donnelly BJ, Saliken JC, et al. Quality of life and sexuality of men with prostate cancer 3 years after cryosurgery. Urology. 2002;60(suppl 1):12–18
  9. Steineck G, Helgesen F, Adolfsson J, et al. Quality of life after radical prostatectomy or watchful waiting. N Engl J Med. 2002;347:790–796
  10. Walsh PC. Radical prostatectomy for localized prostate cancer provides durable cancer control with excellent quality of life: a structured debate. J Urol. 2000;163:1802–1807
  11. Long JP, Bahn D, Lee F, et al. Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate. Urology. 2001;57:518–523
  12. Donnelly BJ, Saliken JC, Ernst DS, et al. Prospective trial of cryosurgical ablation of the prostate: five-year results. Urology. 2002;60:645–649
  13. Reis F, Netto NR, Reinato JA, et al. The impact of prostatectomy and brachytherapy in patients with localized prostate cancer. Int Urol Nephrol. 2004;36:187–190
  14. Feigenberg SJ, Lee WR, Desilvio ML, et al. Health-related quality of life in men receiving prostate brachytherapy on RTOG 98-05. Int J Radiat Oncol Biol Phys. 2005;62:956–964
  15. Madalinska JB, Essink-Bot ML, de Koning HJ, et al. Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer. J Clin Oncol. 2001;19:1619–1628
  16. Potosky AL, Legler J, Albertsen PC, et al. Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study. J Natl Cancer Inst. 2000;92:1582–1592
  17. Zelefsky MJ, Fuks Z, Hunt M, et al. High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys. 2002;53:1111–1116
  18. Brabbins D, Martinez A, Yan D, et al. A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: analysis of chronic toxicity. Int J Radiat Oncol Biol Phys. 2005;61:400–408
  19. Bahn DK, Lee F, Badalament R, et al. Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology. 2002;60(suppl 1):3–11
  20. Incrocci L. Radiation therapy for prostate cancer and erectile (dys)function: the role of imaging. Acta Oncol. 2005;44:673–678

PII: S0090-4295(07)01813-4

doi: 10.1016/j.urology.2007.07.036

Urology
Volume 70, Issue 6, Supplement 1 , Pages S9-S15 , December 2007

Article Tools

* Image Usage & Resolution